Heart Beat January 2011 Issue

Heart Beat: January 2011

Cardiologists prescribe cholesterol-lowering statins to help patients reduce their risk of heart attack or stroke by lowering their LDL cholesterol levels. Physicians now can provide statins to patients without high cholesterol but who have elevated levels of inflammation or C-reactive protein (CRP), which has been identified as a major risk factor for cardiovascular disease. The U.S. Food and Drug Administration approved the use of rosuvastatin (Crestor) based on the results of an international study, JUPITER. It found that healthy people with normal or low cholesterol but high CRP who took rosuvastatin cut their risk of death from heart attack or stroke by 44 percent compared with placebo-treated patients.

To continue reading this article you must be a paid subscriber.

Subscribe to Heart Advisor

Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.

With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.